Cardiac magnetic resonance(CMR)imaging could enable major advantages when guiding in real-time cardiac electrophysiology procedures offering high-resolu-tion anatomy,arrhythmia substrate,and ablation lesion visualizat...Cardiac magnetic resonance(CMR)imaging could enable major advantages when guiding in real-time cardiac electrophysiology procedures offering high-resolu-tion anatomy,arrhythmia substrate,and ablation lesion visualization in the absence of ionizing radiation.Over the last decade,technologies and platforms for performing electrophysiology procedures in a CMR environment have been developed.However,performing procedures outside the conventional fluoro-scopic laboratory posed technical,practical and safety concerns.The development of magnetic resonance imaging compatible ablation systems,the recording of high-quality electrograms despite significant electromagnetic interference and reliable methods for catheter visualization and lesion assessment are the main limiting factors.The first human reports,in order to establish a procedural workflow,have rationally focused on the relatively simple typical atrial flutter ablation and have shown that CMR-guided cavotricuspid isthmus ablation represents a valid alternative to conventional ablation.Potential expansion to other more complex arrhythmias,especially ventricular tachycardia and atrial fibrillation,would be of essential impact,taking into consideration the widespread use of substrate-based strategies.Importantly,all limitations need to be solved before application of CMR-guided ablation in a broad clinical setting.展开更多
To evaluate in an interventional trial on knee osteoarthritis(OA) the level and change of two serum biomarkers and their correlation with imaging parameters.The previously reported interventional OA study(ClinicalT...To evaluate in an interventional trial on knee osteoarthritis(OA) the level and change of two serum biomarkers and their correlation with imaging parameters.The previously reported interventional OA study(ClinicalTrials.gov:NCT00536302) identified a positive effect of collagen hydrolysate(CH) on cartilage morphology in patients with knee OA using delayed gadolinium enhanced magnetic resonance imaging(dGEMRIC).It was the objective in this research project to evaluate in an interventional clinical trial on knee OA the level and change of two serum biomarkers and their correlation with imaging parameters.In blood samples of study participants,we determined the concentration of procollagen type II N-terminal propeptide(PIIANP) and aggrecan chondroitin sulfate 846 epitope(CS846) at baseline(BL) and at the follow-up(FU) visits at 24 and 48 weeks.We measured the level and change of biomarker concentrations in both study groups,and the correlation of those changes with changes in dGEMRIC.For the biomarker PIIANP,we observed a significantly greater increase in the CH group(29.9%vs.1.2%at week 24,P =0.001).For CS846,the mean concentration was lower among the CH treated participants at 24 weeks(78%vs.96%,P= 0.045).Consistent correlations of changes in biomarkers PIIANP and CS846 with changes of the dGEMRIC score could not be observed.In this study,different changes per treatment group,CH and placebo were seen for dGEMRIC and PIIANP BL to 24 weeks FU,but only weak correlations between changes in dGEMRIC and biochemical markers.展开更多
文摘Cardiac magnetic resonance(CMR)imaging could enable major advantages when guiding in real-time cardiac electrophysiology procedures offering high-resolu-tion anatomy,arrhythmia substrate,and ablation lesion visualization in the absence of ionizing radiation.Over the last decade,technologies and platforms for performing electrophysiology procedures in a CMR environment have been developed.However,performing procedures outside the conventional fluoro-scopic laboratory posed technical,practical and safety concerns.The development of magnetic resonance imaging compatible ablation systems,the recording of high-quality electrograms despite significant electromagnetic interference and reliable methods for catheter visualization and lesion assessment are the main limiting factors.The first human reports,in order to establish a procedural workflow,have rationally focused on the relatively simple typical atrial flutter ablation and have shown that CMR-guided cavotricuspid isthmus ablation represents a valid alternative to conventional ablation.Potential expansion to other more complex arrhythmias,especially ventricular tachycardia and atrial fibrillation,would be of essential impact,taking into consideration the widespread use of substrate-based strategies.Importantly,all limitations need to be solved before application of CMR-guided ablation in a broad clinical setting.
基金The original interventional study(NCT00536302) had been sponsored by the company Gelita and the company-specific brand of CH had been used
文摘To evaluate in an interventional trial on knee osteoarthritis(OA) the level and change of two serum biomarkers and their correlation with imaging parameters.The previously reported interventional OA study(ClinicalTrials.gov:NCT00536302) identified a positive effect of collagen hydrolysate(CH) on cartilage morphology in patients with knee OA using delayed gadolinium enhanced magnetic resonance imaging(dGEMRIC).It was the objective in this research project to evaluate in an interventional clinical trial on knee OA the level and change of two serum biomarkers and their correlation with imaging parameters.In blood samples of study participants,we determined the concentration of procollagen type II N-terminal propeptide(PIIANP) and aggrecan chondroitin sulfate 846 epitope(CS846) at baseline(BL) and at the follow-up(FU) visits at 24 and 48 weeks.We measured the level and change of biomarker concentrations in both study groups,and the correlation of those changes with changes in dGEMRIC.For the biomarker PIIANP,we observed a significantly greater increase in the CH group(29.9%vs.1.2%at week 24,P =0.001).For CS846,the mean concentration was lower among the CH treated participants at 24 weeks(78%vs.96%,P= 0.045).Consistent correlations of changes in biomarkers PIIANP and CS846 with changes of the dGEMRIC score could not be observed.In this study,different changes per treatment group,CH and placebo were seen for dGEMRIC and PIIANP BL to 24 weeks FU,but only weak correlations between changes in dGEMRIC and biochemical markers.